Albireo Pharma Inc logo

ALBO

Albireo Pharma Inc

$44.15

Earnings Summary

Revenue
$9.83Mn
Net Profits
$-37.8Mn
Net Profit Margins
-384.46%

Highlights

Revenue:

Albireo Pharma Inc’s revenue jumped 168.34% since last year same period to $9.83Mn in the Q3 2022. On a quarterly growth basis, Albireo Pharma Inc has generated 19.81% jump in its revenue since last 3-months.

Net Profits:

Albireo Pharma Inc’s net profit fell -166.22% since last year same period to $-37.8Mn in the Q3 2022. On a quarterly growth basis, Albireo Pharma Inc has generated 5.38% jump in its net profits since last 3-months.

Net Profit Margins:

Albireo Pharma Inc’s net profit margin fell -124.68% since last year same period to -384.46% in the Q3 2022. On a quarterly growth basis, Albireo Pharma Inc has generated 21.03% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Albireo Pharma Inc post its latest quarter earnings

EPS Estimate Current Quarter
-1.83
EPS Estimate Current Year
-1.83

Highlights

EPS Estimate Current Quarter:

Albireo Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -1.83 - a -72.64% fall from last quarter’s estimates.

EPS Estimate Current Year:

Albireo Pharma Inc’s earning per share (EPS) estimates for the current year stand at -1.83.

Key Ratios

Key ratios of the Albireo Pharma Inc post its Q3 2022 earnings

Earning Per Share (EPS)
-1.92

Highlights

Earning Per Share (EPS):

Albireo Pharma Inc’s earning per share (EPS) fell -166.21% since last year same period to -1.92 in the Q3 2022. This indicates that the Albireo Pharma Inc has generated -166.21% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-16
-1.85
-2.19
-18.38%
2022-11-08
-1.06
-1.92
-81.13%
2022-08-15
-1.65
-2.04
-23.64%